Latest Anika Therapeutics Inc (ANIK) Headlines Uptrend

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Anika Therapeutics Inc (ANIK) Headlines

Uptrend Call Working As Anika Therapeutics Stock Rises 21.7% (ANIK)
Comtex SmarTrend(R) - Mon Mar 10, 9:18AM CDT
SmarTrend identified an Uptrend for Anika Therapeutics (NASDAQ:ANIK) on February 21st, 2014 at $34.68. In approximately 2 weeks, Anika Therapeutics has returned 21.70% as of today's recent price of $42.20.

Mutual Funds Loading Up On These 3 Top-Rated Stocks
at Investor's Business Daily - Fri Mar 07, 7:02AM CST
Investors who follow the big money to snag prospective stock winners will find their way to Ubiquiti Networks (UBNT), Diamondback Energy (FANG) and Anika Therapeutics (ANIK) . Today's Screen Of The Day is Accelerating Mutual Fund Ownership....

Global and Chinese Hyaluronic Acid Solution Industry Report 2014
M2 - Wed Mar 05, 2:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/g7vv9d/global_and) has announced the addition of the "Global and Chinese Hyaluronic Acid Solution Industry Report 2014" report to their offering. The Global and Chinese Hyaluronic Acid Solution Industry Report 2014 is a professional and in-depth study on the current state of the global hyaluronic acid solution industry with a focus on the Chinese situation. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. Hyaluronic acid solution market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Hyaluronic acid solution industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. A key feature of the report is its focus on key industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. Hyaluronic acid solution industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered - Hyaluronic Acid Solution Industry Overview - Hyaluronic Acid Solution International and China Market Analysis - Hyaluronic Acid Solution Development Environmental Analysis - Hyaluronic Acid Solution Development Policy and Plan - Hyaluronic Acid Solution Manufacturing Process and Cost Structure - 2009-2014 Hyaluronic Acid Solution Productions Supply Sales Demand Market Status and Forecast - Hyaluronic Acid Solution Key Manufacturers Analysis - Up and Down Stream Industry Analysis - Hyaluronic Acid Solution Marketing Channels Analysis - 2014-2019 Hyaluronic Acid Solution Productions Supply Sales Demand Market Status and Forecast - Hyaluronic Acid Solution Industry Development Proposals - Hyaluronic Acid Solution New Project Investment Feasibility Analysis - Global and China Hyaluronic Acid Solution Industry Research Conclusions Companies Mentioned - Abbott Medical Optics - Allergan - Anika Therapeutics - Bausch Lomb - Bloomage Freda - CONTIPRO - Changzhou Institute of Material Medical - EME - Ferring Pharmaceuticals - Genzyme Biosurgery - Hangzhou Gallop - Hao Hai Healthcare - Henan Universe IOL - Hyaltech - Jingfeng - LG LIFE & SCIENCE - Lipo Chemicals - Medicis Aesthetics - Merz Pharmaceuticals - Novozymes - Q-Med - Seikagaku - Shiseido - Singclean Medical - Stanford Chemicals - Synvisc-One For more information visit http://www.researchandmarkets.com/research/g7vv9d/global_and About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.

Anika Therapeutics to Present at Canaccord Genuity Musculoskeletal Conference March 11
Business Wire - Tue Mar 04, 3:05PM CST
Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that its President and Chief Executive Officer, Charles H. Sherwood, Ph.D., will be presenting at the 9th Annual Canaccord Genuity Musculoskeletal Conference on Tuesday, March 11, 2014 at 12:30 p.m. ET/ 11:30 a.m. CT. The conference is being held at the Sheraton New Orleans Hotel.

Insider Trading Alert - SWK, ANIK And NYT Traded By Insiders
at The Street - Tue Mar 04, 9:15AM CST
Stocks with insider trader activity include SWK, ANIK and NYT

Ukraine Unrest Sparks Selling But Some Biotechs Firm Up
at Investor's Business Daily - Mon Mar 03, 3:22PM CST
Major averages suffered a setback Monday with closes near lows and losses close to 1%. It's been a while since geopolitical concerns unnerved the market, but Russia's military presence in Ukraine continued to take center stage. The Dow Jones...

Anika Therapeutics (ANIK) Showing Signs Of A Dead Cat Bounce Today
at The Street - Mon Mar 03, 8:55AM CST
Trade-Ideas LLC identified Anika Therapeutics (ANIK) as a "dead cat bounce" (down big yesterday but up big today) candidate

Anika Therapeutics, Inc Surges On Approval, but Is It Overpriced Now?
Todd Campbell, The Motley Fool - Motley Fool - Mon Mar 03, 8:30AM CST
Anika jumped by a third following the FDA's approval of Monovisc, its single injection treatment for osteoarthritis knee pain. The approval concludes a three year process that began when the FDA voted against approving the therapy in...

This Week in Biotech: 2 FDA Approvals and 3 Clinically Impressive Studies
Sean Williams, The Motley Fool - Motley Fool - Sat Mar 01, 2:15PM CST
With the  SPDR S&P Biotech Index  up  75% over the trailing-12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and...

FDA Approval and a Generic-Drug Maker Arms Race Propel Winners
David Williamson, The Motley Fool - Motley Fool - Thu Feb 27, 8:39PM CST
Anika Therapeutics is the big winner in biotech this week, with shares having increased by a third of their value after receiving FDA approval for Monovisc, an osteoarthritis treatment injected directly into the knee.  Johnson & Johnson  will...

Norcraft Companies Schedules Earnings Release and Conference Call for Fourth Quarter and Full Year 2013 Results
Business Wire - Thu Feb 27, 6:01AM CST
Norcraft Companies, Inc. ("we," the "Company" or "Norcraft") (NYSE:NCFT), a leading manufacturer of kitchen and bathroom cabinetry in the United States and Canada, announced today that the Company will release its fourth quarter and full year 2013 financial results before the market opens on Tuesday, March 25, 2014. A conference call will be held that same day at 10:00 a.m. Eastern time to review fourth quarter and full year 2013 results, discuss recent events and conduct a question-and-answer period.

Chesapeake Energy Falls after Missing Estimates; Anika Therapeutics Gets FDA Approval for Monovisc
ACCESSWIRE - Thu Feb 27, 12:16AM CST
Chesapeake Energy Corporation (NYSE: CHK) - For an in-depth report on Chesapeake Energy Corporation follow: www.BullTrends.com/stockquote/CHK

Anika rises on drug approval
at Investor's Business Daily - Wed Feb 26, 5:42PM CST
The biotech's shares leapt 33.2% to 45.90 a day after it won FDA approval for its arthritis treatment. After the close Tue., Anika Therapeutics (ANIK) said the FDA had approved Monovisc for osteoarthritis of the knee. DePuy Synthes Mitek Sports...

Nasdaq stocks posting largest volume increases
AP - Wed Feb 26, 5:07PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:

Nasdaq stocks posting largest percentage increases
AP - Wed Feb 26, 5:07PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:

SmarTrend Watching for Potential Pullback in Shares of Anika Therapeutics After 33.16% Gain
Comtex SmarTrend(R) - Wed Feb 26, 4:20PM CST
Anika Therapeutics (NASDAQ:ANIK) traded in a range yesterday that spanned from a low of $43.50 to a high of $52.49. Yesterday, the shares gained 33.2%, which took the trading range above the 3-day high of $35.53 on volume of 6.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Why Anika Therapeutics, Amyris, and ExamWorks Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Wed Feb 26, 4:15PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. The recipe for market weakness remains the same yet again --...

Stocks Close With Modest Gains, But Homebuilders Surge
at Investor's Business Daily - Wed Feb 26, 3:22PM CST
Major averages managed small gains Wednesday, recovering a bit after getting spooked by comments from Boston Fed President Eric Rosengren. He cited significant job market slack in a speech to the Boston Economic Club. The Dow Jones industrial average...

Anika Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results
Business Wire - Wed Feb 26, 3:05PM CST
--EPS Increases 42% to $0.44 in Quarter and 70% to $1.39 for Year

Anika Therapeutics Inc. (ANIK) Stock Research Links

ANIK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 261

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 255

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 176

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 211

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 102

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 128

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 199

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 99

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 175

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 374

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading

Top 5 Most Recently Viewed Articles

Crédit Agricole Assurances Reports Remarkable Growth in 2024

Updated Category News Views 81

Crédit Agricole Assurances Reports Remarkable Growth in 2024 Crédit Agricole Assurances recently revealed their impressive performance for the first nine months of 2024, showcasing an 18.2% increase in total revenue, amounting to €32.8 billion. This significant growth reflects the company's dedication to its clients and the effectiveness of its diverse insurance...

Continue Reading
Enerpac Tool Group's Earnings Preview and Stock Insights

Updated Category News Views 72

Enerpac Tool Group's Upcoming Earnings Announcement Enerpac Tool Group (NYSE: EPAC) is set to release its quarterly earnings report shortly. This announcement is pivotal for both current investors and those considering an investment in the company. With analysts predicting an earnings per share (EPS) of $0.53, excitement is building around whether Enerpac will meet or...

Continue Reading
Unlocking Sales Potential: The Power of Unified Measurement

Updated Category News Views 163

Unlocking Sales Potential: The Power of Unified Measurement Marketing teams are faced with the challenge of demonstrating their impact amidst shifting sales channels. With the rise of platforms like Amazon, TikTok Shop, and other marketplaces, traditional measurement tools have fallen short, often focusing solely on .com sales. This shortfall can lead to up to 42% of...

Continue Reading
Rigel Pharmaceuticals Prepares for 2024 Financial Results Call

Updated Category News Views 81

Rigel Pharmaceuticals to Announce Fourth Quarter Results Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) has made an important announcement detailing its plans to share its financial performance for the fourth quarter and the full year of 2024. This financial disclosure is scheduled to occur after the market closes on a day soon approaching in March. Details on the Conference...

Continue Reading
DENSO Partners for Michigan Workforce Development Initiatives

Updated Category News Views 213

DENSO Collaborates to Enhance Michigan's Workforce DENSO, a prominent mobility supplier, is making significant strides in workforce development by partnering with local businesses and organizations in Michigan. This collaboration has successfully secured over $550,000 in workforce training grants aimed at supporting leadership and skilled trades upskilling in the region....

Continue Reading